West Pharmaceutical Services (WST)
(Delayed Data from NYSE)
$377.33 USD
-0.03 (-0.01%)
Updated Apr 18, 2024 04:00 PM ET
After-Market: $377.08 -0.25 (-0.07%) 7:30 PM ET
3-Hold of 5 3
D Value B Growth F Momentum D VGM
Fundamental Charts
About Cash from Investing (Quarterly)
The company's quarterly Cash from Investing value is the sum of the company's current quarter cash position resulting from any gains or losses from investments in the financial markets, operating activities, and changes resulting from amounts spent on investments in capital assets such as plant and equipment. When evaluating the Cash from Investing value, it is important to consider each of the various activities which contribute to the overall change in cash position. A company can have a negative cash flow from investing and have a positive cash from Cash from operations or financing.
WST 377.33 -0.03(-0.01%)
Will WST be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for WST based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for WST
West Pharmaceutical Services (WST) Expected to Beat Earnings Estimates: Should You Buy?
Reasons to Hold West Pharmaceutical (WST) in Your Portfolio Now
WST: What are Zacks experts saying now?
Zacks Private Portfolio Services
Merit Medical (MMSI) Down 0.6% Since Last Earnings Report: Can It Rebound?
Why Is Henry Schein (HSIC) Down 1.8% Since Last Earnings Report?
Reasons to Hold West Pharmaceutical (WST) in Your Portfolio Now
Other News for WST
Strong Buy: West Pharmaceutical Services’ Market Position and Growth Prospects in Drug Packaging Industry
West to Host First-Quarter 2024 Conference Call
West Pharmaceutical Services Inc. stock underperforms Tuesday when compared to competitors
(WST) - Analyzing West Pharmaceutical Servs's Short Interest
West Pharmaceutical Services Inc (WST)'s Winning Formula: Financial Metrics and Competitive ...